NexGel Q4 EPS $(0.12) Misses $(0.09) Estimate, Sales $2.796M Miss $3.240M Estimate

3/31/2026
Impact: -70
Healthcare

NexGel (NASDAQ: NXGL) reported a Q4 loss of $(0.12) per share, missing the analyst estimate of $(0.09) by 33.33%. This represents a 9.09% increase in losses compared to $(0.11) per share in the same period last year. The company's quarterly sales were $2.796 million, falling short of the $3.240 million estimate by 13.70%, and marking an 8.03% decrease from $3.040 million in the prior year.

AI summary, not financial advice

Share: